Upcoming AWS Coverage on Premier Post-Earnings Results

LONDON, UK / ACCESSWIRE / May 23, 2017 / Active Wall St. blog coverage looks at the headline from the leader in telehealth services, Teladoc, Inc. (NYSE: TDOC), as the Company announced on May 19, 2017, that as a result of the new landmark telemedicine bill in Texas, the Company will expand its telehealth offering in the state, a move seen as re-activation of Teladoc's industry-leading video capabilities. Senate Bill 1107 will soon be signed into law, establishing Texas as the national leader in telemedicine and thus, will mark the close of Teladoc's six-year legal dispute in the state regarding the proper scope and use of telemedicine. Register with us now for your free membership and blog access at:

http://www.activewallst.com/register/

One of Teladoc's competitors within the Healthcare Information Services space, Premier, Inc. (NASDAQ: PINC), disclosed on May 08, 2017, its financial results for Q3 FY17 which ended on March 31, 2017. AWS will be initiating a research report on Premier in the coming days.

Today, AWS is promoting its blog coverage on TDOC; touching on PINC. Get all of our free blog coverage and more by clicking on the link below:

http://www.activewallst.com/register/

The Legal Dispute

The case between Teladoc and Texas Medical Board concerns whether anti-telemedicine regulations levied by the board constitute a violation of antitrust laws. Teladoc sued the Texas Medical Board (TMB) in April 2015 citing that the board was made up of practicing doctors with a financial interest in limiting telemedicine; the board's passing of anti-telemedicine legislation constituted a violation of the antitrust laws. The medical board filed a motion seeking the suit's dismissal on the ground that there is, in fact, state supervision of the medical board which would make it a state agency under the law and therefore immune to legal suits.

Later, on October 17, 2016, the Texas and its state medical board withdrew their appeal that questioned if Teladoc could challenge the state's controversial telemedicine restrictions. Texas is experiencing a severe physician shortage with 35 counties lacking a single practicing physician within their boundaries. Teladoc has stated in its court filings that telemedicine can help bridge this gap, as it is cheaper than traditional on-site doctors or emergency room visits.

The Announcement

The Company announced that under this new law, a patient-physician relationship can be established without an in-person visit, protecting all forms of telemedicine. Teladoc has been operating in the area since 2005 where more than 3 million Texans have access to Teladoc, including 2,500 Texas clients.

In addition to protecting the right to telemedicine, the bill puts in place a regulatory environment that paves the way to transform the healthcare experience with future innovation. Texas is set to benefit considerably from the pending law as Texas faces some of the largest healthcare barriers in the country where Texas ranks 46th among the 50 states in terms of primary care physicians per capita, with only 71.4 PCPs per 100,000 residents.

Teladoc Growth Prospects

Teladoc's is the US leading provider of telehealth services and the Company offers a virtual care visit in the present health care ecosystem. The Company serves about 7,500 clients, including health plans, health systems, employers, and other organizations, where more than 20 million members can leverage Teladoc's network of more than 3,100 board-certified, state-licensed physicians.

Earnings Highlights and other Updates

On March 16, 2017, Teladoc announced an alliance with Accolade, an on-demand healthcare concierge for employers, health plans, and health systems. The Companies will eventually help members better navigate their health care benefit options and hence, maximize the value of their telehealth benefits while contributing to an efficient and positive health care experience.

Teladoc recently announced its Q1 FY17 results on May 08, 2017. The Company reported net revenue of $42.9 million for the three-month period ending, March 31, 2017, which was 60% higher than the net revenue for Q1 FY16. The Company incurred a net loss of $15.7 million in Q1 FY17 which was 4% less than the $15.3 million loss for Q1 FY16.

Stock Performance

Teladoc's stock price fell by 3.88%, closing Monday's session at $28.50 on volume of 751.94 thousand shares. The Company's stock price soared 10.68% in the last month, 37.02% in the past three months, and 63.32% in the previous six months. Furthermore, on a year to date basis, the stock skyrocketed 72.73%. At Monday's closing price, the stock's net capitalization stands at $1.49 billion.

Active Wall Street:

Active Wall Street (AWS) produces regular sponsored and non-sponsored reports, articles, stock market blogs, and popular investment newsletters covering equities listed on NYSE and NASDAQ and micro-cap stocks. AWS has two distinct and independent departments. One department produces non-sponsored analyst certified content generally in the form of press releases, articles and reports covering equities listed on NYSE and NASDAQ and the other produces sponsored content (in most cases not reviewed by a registered analyst), which typically consists of compensated investment newsletters, articles and reports covering listed stocks and micro-caps. Such sponsored content is outside the scope of procedures detailed below.

AWS has not been compensated; directly or indirectly; for producing or publishing this document.

PRESS RELEASE PROCEDURES:

The non-sponsored content contained herein has been prepared by a writer (the "Author") and is fact checked and reviewed by a third party research service company (the "Reviewer") represented by a credentialed financial analyst, for further information on analyst credentials, please email info@activewallst.com. Rohit Tuli, a CFA® charterholder (the "Sponsor"), provides necessary guidance in preparing the document templates. The Reviewer has reviewed and revised the content, as necessary, based on publicly available information which is believed to be reliable. Content is researched, written and reviewed on a reasonable-effort basis. The Reviewer has not performed any independent investigations or forensic audits to validate the information herein. The Reviewer has only independently reviewed the information provided by the Author according to the procedures outlined by AWS. AWS is not entitled to veto or interfere in the application of such procedures by the third-party research service company to the articles, documents or reports, as the case may be. Unless otherwise noted, any content outside of this document has no association with the Author or the Reviewer in any way.

NO WARRANTY

AWS, the Author, and the Reviewer are not responsible for any error which may be occasioned at the time of printing of this document or any error, mistake or shortcoming. No liability is accepted whatsoever for any direct, indirect or consequential loss arising from the use of this document. AWS, the Author, and the Reviewer expressly disclaim any fiduciary responsibility or liability for any consequences, financial or otherwise arising from any reliance placed on the information in this document. Additionally, AWS, the Author, and the Reviewer do not (1) guarantee the accuracy, timeliness, completeness or correct sequencing of the information, or (2) warrant any results from use of the information. The included information is subject to change without notice.

NOT AN OFFERING

This document is not intended as an offering, recommendation, or a solicitation of an offer to buy or sell the securities mentioned or discussed, and is to be used for informational purposes only. Please read all associated disclosures and disclaimers in full before investing. Neither AWS nor any party affiliated with us is a registered investment adviser or broker-dealer with any agency or in any jurisdiction whatsoever. To download our report(s), read our disclosures, or for more information, visit http://www.activewallst.com/disclaimer/.

CONTACT

For any questions, inquiries, or comments reach out to us directly. If you're a company we are covering and wish to no longer feature on our coverage list contact us via email and/or phone between 09:30 EDT to 16:00 EDT from Monday to Friday at:

Email: info@activewallst.com

Phone number: 1-858-257-3144

Office Address: 3rd floor, 207 Regent Street, London, W1B 3HH, United Kingdom

CFA® and Chartered Financial Analyst® are registered trademarks owned by CFA Institute.

SOURCE: Active Wall Street